These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15887248

  • 21. Antiandrogen-induced cell death in LNCaP human prostate cancer cells.
    Lee EC, Zhan P, Schallhom R, Packman K, Tenniswood M.
    Cell Death Differ; 2003 Jul; 10(7):761-71. PubMed ID: 12815459
    [Abstract] [Full Text] [Related]

  • 22. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
    Wang Y, Shao C, Shi CH, Zhang L, Yue HH, Wang PF, Yang B, Zhang YT, Liu F, Qin WJ, Wang H, Shao GX.
    Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
    [Abstract] [Full Text] [Related]

  • 23. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Gravina GL, Festuccia C, Millimaggi D, Dolo V, Tombolini V, de Vito M, Vicentini C, Bologna M.
    Prostate; 2008 May 15; 68(7):793-801. PubMed ID: 18324645
    [Abstract] [Full Text] [Related]

  • 24. Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth.
    Peternac D, Klima I, Cecchini MG, Studer UE, Thalmann GN.
    J Urol; 2006 Jul 15; 176(1):354-60. PubMed ID: 16753443
    [Abstract] [Full Text] [Related]

  • 25. Increased resistance to trail-induced apoptosis in prostate cancer cells selected in the presence of bicalutamide.
    Mitterberger M, Neuwirt H, Cavarretta IT, Hobisch A, Culig Z.
    Prostate; 2007 Aug 01; 67(11):1194-201. PubMed ID: 17520660
    [Abstract] [Full Text] [Related]

  • 26. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM, Frazier MC, Harris WB.
    Anticancer Res; 2007 Aug 01; 27(3B):1483-8. PubMed ID: 17595765
    [Abstract] [Full Text] [Related]

  • 27. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T.
    Cancer Invest; 2007 Feb 01; 25(1):32-7. PubMed ID: 17364555
    [Abstract] [Full Text] [Related]

  • 28. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
    Banham AH, Boddy J, Launchbury R, Han C, Turley H, Malone PR, Harris AL, Fox SB.
    Prostate; 2007 Jul 01; 67(10):1091-8. PubMed ID: 17477366
    [Abstract] [Full Text] [Related]

  • 29. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC, Astapova I, Hollenberg AN, Balk SP.
    Cancer Res; 2007 Sep 01; 67(17):8388-95. PubMed ID: 17804755
    [Abstract] [Full Text] [Related]

  • 30. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.
    Pang ST, Flores-Morales A, Skoog L, Chuan YC, Nordstedt G, Pousette A.
    Oncol Rep; 2004 Jun 01; 11(6):1187-92. PubMed ID: 15138554
    [Abstract] [Full Text] [Related]

  • 31. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells.
    Makkonen H, Kauhanen M, Jääskeläinen T, Palvimo JJ.
    Mol Cell Endocrinol; 2011 Jan 01; 331(1):57-65. PubMed ID: 20728506
    [Abstract] [Full Text] [Related]

  • 32. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.
    Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538
    [Abstract] [Full Text] [Related]

  • 33. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
    Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S.
    J Cell Biochem; 2006 Aug 15; 98(6):1408-23. PubMed ID: 16619263
    [Abstract] [Full Text] [Related]

  • 34. Calmodulin-androgen receptor (AR) interaction: calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells.
    Pelley RP, Chinnakannu K, Murthy S, Strickland FM, Menon M, Dou QP, Barrack ER, Reddy GP.
    Cancer Res; 2006 Dec 15; 66(24):11754-62. PubMed ID: 17178871
    [Abstract] [Full Text] [Related]

  • 35. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
    Tsui KH, Hsieh WC, Lin MH, Chang PL, Juang HH.
    Prostate; 2008 May 01; 68(6):610-9. PubMed ID: 18196550
    [Abstract] [Full Text] [Related]

  • 36. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S.
    Prostate; 2005 Dec 01; 65(4):287-98. PubMed ID: 16015608
    [Abstract] [Full Text] [Related]

  • 37. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
    Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, Zhau HE, Chung LW.
    Prostate; 2007 May 15; 67(7):722-31. PubMed ID: 17342749
    [Abstract] [Full Text] [Related]

  • 38. [Transcriptional regulation of placental transforming growth factor-beta by calcitriol in prostate cancer cells is androgen-independent].
    Nazarova NIu, Chikhirzhina GI, Tuohimaaa P.
    Mol Biol (Mosk); 2006 May 15; 40(1):84-9. PubMed ID: 16523695
    [Abstract] [Full Text] [Related]

  • 39. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells.
    Wang Y, Kreisberg JI, Bedolla RG, Mikhailova M, deVere White RW, Ghosh PM.
    Oncogene; 2007 Sep 06; 26(41):6061-70. PubMed ID: 17420725
    [Abstract] [Full Text] [Related]

  • 40. Biphasic effect of androgens on prostate cancer cells and its correlation with androgen receptor coactivator dopa decarboxylase.
    Shao C, Wang Y, Yue HH, Zhang YT, Shi CH, Liu F, Bao TY, Yang ZY, Yuan JL, Shao GX.
    J Androl; 2007 Sep 06; 28(6):804-12. PubMed ID: 17581945
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.